PUBLISHER: IMARC | PRODUCT CODE: 1370593
PUBLISHER: IMARC | PRODUCT CODE: 1370593
The global telemedicine market size reached US$ 59.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 218.0 Billion by 2028, exhibiting a growth rate (CAGR) of 21.9% during 2023-2028.
Telemedicine is the remote delivery of healthcare services, such as consultations or assessments, via telephone networks without the requirement for an in-person visit. There are several components to a telemedicine system, such as hardware, software, and a communication channel, that allow information to be exchanged between two geographical locations. Using telecommunication infrastructures, remote delivery of healthcare services can be performed efficiently. In addition to this, follow-up visits, management of chronic conditions, medication management, and specialist consultations can also be managed via text, audio and video conferences. Remote access to physicians not only makes it easier for patients to connect with them, but it can also help reduce overall healthcare costs. As a result, medical practitioners and hospitals alike are looking forward to implementing digital health technologies in their practices.
The market is majorly driven by the rapid digitization in the medical sector across the globe. This can be attributed to continual technological advancements for making healthcare affordable and accessible to the masses. In addition to this, the integration of advanced technologies, such as machine learning (ML), artificial intelligence (AI), and the Internet of Things (IoT), is resulting in a higher product uptake on the global level. The proliferation of e-visits, along with the rapid expansion of radiology, cardiology, and mental health segments, is resulting in the development of new business and healthcare models, thereby propelling the market. Apart from this, the rising prevalence of chronic diseases, including diabetes and cancer, as well as a lack of adequate healthcare services in underdeveloped regions, is increasing the demand for telemedicine across the globe. Some of the other factors contributing to the market include continuous postponement and cancellation of elective surgeries and appointments due to social distancing norms during COVID-19, fierce market competition among key players, the launch of numerous innovative products, such as smart medicine cabinets, and extensive research and development (R&D) activities.
IMARC Group provides an analysis of the key trends in each sub-segment of the global telemedicine market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, modality, delivery mode, facility, application and end user.
Product
Hardware
Software
Others
Services
Tele-consulting
Tele-monitoring
Tele-education
Real-time
Store and Forward
Others
Web/Mobile
Audio/Text-based
Visualized
Call Centers
Tele-hospital
Tele-home
Teledermatology
Teleradiology
Telepsychiatry
Telepathology
Telecardiology
Others
Providers
Payers
Patients
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aerotel Medical Systems (1998) Ltd., Allscripts Healthcare Solutions Inc., AMD Global Telemedicine Inc., American Well Corporation, Cigna Corporation, Cisco Systems Inc., Doxy.me Inc., HealthTap Inc., PlushCare Inc. (Accolade Inc.), SHL Telemedicine, SOC Telemed Inc. (Patient Square Capital), Teladoc Health Inc. and Twilio Inc.